Department of Clinical Biochemistry, Derriford Hospital, Plymouth PL6 8DH, UK.
Ann Clin Biochem. 2010 May;47(Pt 3):259-63. doi: 10.1258/acb.2009.009061. Epub 2009 Sep 9.
Measurement of the faecal markers calprotectin, lactoferrin and tumour M2-PK has been reported to be useful in the diagnosis and management of a range of gastrointestinal disorders in both children and adults. The aim of this study was to investigate the requirement for age-related reference ranges.
Faecal samples were obtained from 132 healthy subjects and analysis of calprotectin, lactoferrin and tumour M2-PK performed using commercially available enzyme-linked immunosorbent assay.
In the healthy subjects median concentrations were as follows: for calprotectin - 2-9 y, 34 microg/g, 10-59 y, 22 microg/g and > or =60 y, 27 microg/g; for lactoferrin - 2-9 y, 2.2 microg/g, > or =10 y, 0.5 microg/g; and for tumour M2-PK all subjects <1 U/mL. Significant differences between age groups for different markers resulted in the following age-related reference ranges: calprotectin - 2-9 y, <166 microg/g, 10-59 y, <51 microg/g, > or =60 y, <112 microg/g; lactoferrin - 2-9 y, <29 microg/g, > or =10 y <4.6 microg/g.
In healthy individuals, we found there to be variation in the faecal inflammatory markers calprotectin and lactoferrin with age. For both calprotectin and lactoferrin children aged 2-9 y had significantly higher concentrations than subjects aged >/=10 y. For calprotectin but not lactoferrin, adults > or =60 years had a higher concentration than those aged 10-59 y. There was no change with age in the metabolomic marker faecal tumour M2-PK in healthy subjects. The knowledge of age-related reference ranges in healthy subjects is important to fully interpret changes in gastrointestinal disease.
已有报道称粪便标志物钙卫蛋白、乳铁蛋白和肿瘤 M2-PK 的测定在儿童和成人的一系列胃肠道疾病的诊断和治疗中具有一定的作用。本研究旨在探讨建立年龄相关参考范围的必要性。
采集 132 例健康受试者的粪便样本,使用商用酶联免疫吸附试验分析钙卫蛋白、乳铁蛋白和肿瘤 M2-PK。
在健康受试者中,中位数浓度如下:钙卫蛋白-2-9 岁,34μg/g;10-59 岁,22μg/g;>/=60 岁,27μg/g;乳铁蛋白-2-9 岁,2.2μg/g;>/=10 岁,0.5μg/g;肿瘤 M2-PK 所有受试者<1U/mL。不同标志物的年龄组间存在显著差异,导致以下年龄相关参考范围:钙卫蛋白-2-9 岁,<166μg/g;10-59 岁,<51μg/g;>/=60 岁,<112μg/g;乳铁蛋白-2-9 岁,<29μg/g;>/=10 岁,<4.6μg/g。
在健康个体中,我们发现粪便炎症标志物钙卫蛋白和乳铁蛋白的浓度随年龄而变化。对于钙卫蛋白和乳铁蛋白,2-9 岁儿童的浓度显著高于>/=10 岁的受试者。对于钙卫蛋白,但不是乳铁蛋白,>/=60 岁的成年人的浓度高于 10-59 岁的成年人。在健康受试者中,代谢标志物粪便肿瘤 M2-PK 随年龄无变化。了解健康受试者的年龄相关参考范围对于充分解释胃肠道疾病的变化非常重要。